Craig Wheeler

Insider Reports History

Entity
Individual
Signature
/s/ David Watson, attorney-in-fact for Craig Wheeler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig Wheeler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AMICUS THERAPEUTICS, INC. Director Common Stock 64.2K $642K $10.00 Jun 6, 2024 Direct
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 28.2K $513K $18.20 Apr 17, 2025 Direct
Apellis Pharmaceuticals, Inc. Director Common Stock 16.5K $360K $21.87 Apr 17, 2025 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 42.5K Jun 6, 2024 Direct

Insider Reports Filed by Craig Wheeler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Apr 17, 2025 2 $513K 4 Apr 21, 2025 Director
APLS Apellis Pharmaceuticals, Inc. Apr 17, 2025 0 $0 3 Apr 21, 2025 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director